Literature DB >> 5496233

Uroporphyrinogen 3 cosynthetase in asymptomatic carriers of congenital erythpoietic porphyria.

G Romeo, B L Glenn, E Y Levin.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 5496233     DOI: 10.1007/bf00486385

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


× No keyword cloud information.
  14 in total

1.  A SUGGESTED CONTROL GENE MECHANISM FOR THE EXCESSIVE PRODUCTION OF TYPES I AND 3 PORPHYRINS IN CONGENITAL ERYTHROPOIETIC PORPHYRIA.

Authors:  C J WATSON; W RUNGE; L TADDEINI; I BOSSENMAIER; R CARDINAL
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

2.  Studies on the biosynthesis of uroporphyrin III from porphobilinogen and the behaviour of uroporphyrin esters in paper chromatography.

Authors:  L BOGORAD; G S MARKS
Journal:  Biochim Biophys Acta       Date:  1960-07-01

3.  Differences between the red cell acetylcholinesterase defects of paroxysmal nocturnal hemoglobinuria and of ABO hemolytic disease.

Authors:  F Herz; E Kaplan; E S Scheye
Journal:  Acta Haematol       Date:  1968       Impact factor: 2.195

4.  Isolation and properties of wheat germ uroporphyrinogen 3 cosynthetase.

Authors:  E Stevens; B Frydman
Journal:  Biochim Biophys Acta       Date:  1968-02-05

5.  Hematological and blood chemical observations in neonatal normal and porphyric calves in early life.

Authors:  J J Kaneko; R Mills
Journal:  Cornell Vet       Date:  1970-01

6.  Uroporphyrinogen 3 cosynthetase from mouse spleen.

Authors:  E Y Levin
Journal:  Biochemistry       Date:  1968-11       Impact factor: 3.162

7.  The enzymatic conversion of porphobilinogen to uroporphyrinogen catalyzed by extracts of hematopoietic mouse spleen.

Authors:  E Y Levin; D L Coleman
Journal:  J Biol Chem       Date:  1967-09-25       Impact factor: 5.157

8.  Rate of heme and porphyrin synthesis by bovine porphyric reticulocytes in vitro.

Authors:  J E Smith; J J Kaneko
Journal:  Am J Vet Res       Date:  1966-07       Impact factor: 1.156

9.  Uroporphyrinogen 3 cosynthetase in bovine erythropoietic porphyria.

Authors:  E Y Levin
Journal:  Science       Date:  1968-08-30       Impact factor: 47.728

10.  Uroporphyrinogen 3 cosynthetase in human congenital erythropoietic porphyria.

Authors:  G Romeo; E Y Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205

View more
  12 in total

1.  Regional assignment of the human uroporphyrinogen III synthase (UROS) gene to chromosome 10q25.2----q26.3.

Authors:  K H Astrin; C A Warner; H W Yoo; P J Goodfellow; S F Tsai; R J Desnick
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

2.  Congenital erythropoietic porphyria and congenital adrenal hyperplasia with evidence for hepatic delta-5 alpha-reductase deficiency.

Authors:  J A Miller; G M Levene
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

Review 3.  The porphyrias: a review.

Authors:  G H Elder; C H Gray; D C Nicholson
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

4.  Blood cells as markers for metabolic disorders.

Authors:  E Beutler
Journal:  Blut       Date:  1985-12

5.  Uroporphyrinogen 3 cosynthetase activity in fibroblasts from patients with congenital erythropoietic porphyria.

Authors:  G Romeo; M M Kaback; E Y Levin
Journal:  Biochem Genet       Date:  1970-12       Impact factor: 1.890

6.  Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria.

Authors:  F Mazurier; F Moreau-Gaudry; S Salesse; C Barbot; C Ged; J Reiffers; H de Verneuil
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

7.  Prenatal exclusion of congenital erythropoietic porphyria (Günther's disease) in a fetus at risk.

Authors:  J C Deybach; B Grandchamp; M Grelier; Y Nordmann; J Boué; A Boué; P de Berrianger
Journal:  Hum Genet       Date:  1980-02       Impact factor: 4.132

Review 8.  Porphyrias: animal models and prospects for cellular and gene therapy.

Authors:  H de Verneuil; C Ged; S Boulechfar; F Moreau-Gaudry
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

9.  Erythropoietic porphyria of the fox squirrel Sciurus niger.

Authors:  E Y Levin; V Flyger
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

Review 10.  Enzymatic defects of hereditary porphyrias: an explanation of dominance at the molecular level.

Authors:  G Romeo
Journal:  Hum Genet       Date:  1977-12-23       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.